RTW INVESTMENTS, LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001493215
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2025 · 68 positions · Total reported value $6.54B · Top-10 concentration 52.7% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 37.2% · 10 new · 12 cut · 13 exited
Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -7.3% · vs SPY -9.4% · Prev Value $11.71B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $9.91B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2025 13F filing, RTW INVESTMENTS, LP disclosed 68 equity positions with a combined reported value of $6.54B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q1 2025 were MDGL ($660.37M), ARGX ($398.62M), PTCT ($381.34M). By sector, the heaviest allocations are Health Care 81.6%, Technology 0.3%. Versus the prior quarter, allocation shifted toward Other (+1.5pp) and away from Industrials (-2.2pp).
Versus the prior quarter, RTW INVESTMENTS, LP opened 10 new positions, trimmed 12 and fully exited 13, a turnover rate of 37.2% of positions. The portfolio's overlap with the prior quarter was 71% of names.
The largest new positions opened in Q1 2025 were ISRG ($100.27M), GEHC ($41.97M), BBNX ($40.39M).
Of the 13 positions fully exited versus the prior quarter, the largest were BRKR ($145.44M), ROIV ($17.20M), SAGE ($16.30M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2025)
- ISRG INTUITIVE SURGICAL INC · $100.27M
- GEHC GE HEALTHCARE TECHNOLOGIES I · $41.97M
- BBNX BETA BIONICS INC · $40.39M
- VSTM VERASTEM INC · $25.60M
- TEM TEMPUS AI INC · $19.30M
- GKOS GLAUKOS CORP · $18.70M
- DGX QUEST DIAGNOSTICS INC · $16.75M
- BEAM BEAM THERAPEUTICS INC · $8.57M
Fully Exited (vs previous quarter)
- BRKR BRUKER CORP · prev qtr: $145.44M
- ROIV ROIVANT SCIENCES LTD · prev qtr: $17.20M
- SAGE SAGE THERAPEUTICS INC · prev qtr: $16.30M
- TRML TOURMALINE BIO INC · prev qtr: $14.94M
- DNTH DIANTHUS THERAPEUTICS INC · prev qtr: $14.53M
- IMVT IMMUNOVANT INC · prev qtr: $13.14M · history
- PEPG PEPGEN INC · prev qtr: $12.10M
- IDYA IDEAYA BIOSCIENCES INC · prev qtr: $5.14M
Insider Transactions (Form 4)
Latest RTW INVESTMENTS, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-11-09 | Buy | Orchestra BioMed Holdings, Inc. | 1,200,000 | $5.00 | SEC filing |
| 2026-07-21 | J | ALLURION TECHNOLOGIES, INC. | 1,771 | — | SEC filing |
| 2026-07-21 | J | ALLURION TECHNOLOGIES, INC. | 19,934 | — | SEC filing |
| 2026-07-21 | J | ALLURION TECHNOLOGIES, INC. | 161,807 | — | SEC filing |
| 2026-07-21 | J | ALLURION TECHNOLOGIES, INC. | 209,254 | — | SEC filing |
| 2026-04-27 | Sell | Orchestra BioMed Holdings, Inc. | 32 | $4.13 | SEC filing |
| 2026-04-27 | Opt exercise | Orchestra BioMed Holdings, Inc. | 1,250,032 | $0.00 | SEC filing |
| 2026-04-20 | Buy | Kailera Therapeutics, Inc. | 500,000 | $16.00 | SEC filing |
Fund Profile
RTW Investments, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 84 positions worth $11.71B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-78183 (status: Approved), registered 2013-06-13
- Regulatory AUM (Form ADV): $14.14B as of 2026-03-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 2 hedge funds
- Website: rtwfunds.com
Portfolio Structure
- 84 positions · $11.71B reported value (Q2 2026)
- Top 10 holdings = 47.7% of reported value
- Largest position: MDGL (MADRIGAL PHARMACEUTICALS INC) at 9.1%
- Average position size: $139.44M
Sector Tilt
- Health Care 99.1%
- Industrials 0.4%
- Information Technology 0.4%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 9 new, 24 added, 8 reduced, 13 exited
- 43 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.99M | $660.37M | 10.10% | Hold | |
| 2 |
|
673.50K | $398.62M | 6.10% | Hold | |
| 3 |
|
7.48M | $381.34M | 5.83% | Add | |
| 4 |
|
2.59M | $366.75M | 5.61% | Hold | |
| 5 |
|
2.92M | $340.88M | 5.21% | Reduce | |
| 6 |
|
7.42M | $300.33M | 4.59% | Add | |
| 7 |
|
5.72M | $276.59M | 4.23% | Add | |
| 8 |
|
8.75M | $258.21M | 3.95% | Add | |
| 9 |
|
862.77K | $230.71M | 3.53% | Hold | |
| 10 |
|
3.01M | $229.98M | 3.52% | Hold | |
| 11 |
|
6.88M | $227.33M | 3.48% | Reduce | |
| 12 |
|
590.22K | $219.71M | 3.36% | Hold | |
| 13 |
|
2.85M | $180.87M | 2.77% | Add | |
| 14 |
|
4.17M | $175.49M | 2.68% | Hold | |
| 15 |
|
3.32M | $170.34M | 2.60% | Add | |
| 16 |
|
4.87M | $144.49M | 2.21% | Hold | |
| 17 |
|
8.54M | $141.85M | 2.17% | Reduce | |
| 18 |
|
17.69M | $117.98M | 1.80% | Hold | |
| 19 |
|
2.32M | $115.23M | 1.76% | Add | |
| 20 |
|
683.29K | $113.84M | 1.74% | Hold | |
| 21 |
|
3.14M | $113.36M | 1.73% | Add | |
| 22 |
|
2.72M | $109.36M | 1.67% | Hold | |
| 23 |
|
2.58M | $105.44M | 1.61% | Add | |
| 24 |
|
2.71M | $101.32M | 1.55% | Hold | |
| 25 |
|
202.46K | $100.27M | 1.53% | New | |
| 26 |
|
1.12M | $82.35M | 1.26% | Add | |
| 27 |
|
1.71M | $61.83M | 0.95% | Reduce | |
| 28 |
|
5.50M | $60.66M | 0.93% | Add | |
| 29 |
|
3.62M | $58.44M | 0.89% | Hold | |
| 30 |
|
4.27M | $45.21M | 0.69% | Add | |
| 31 |
|
3.83M | $42.41M | 0.65% | Hold | |
| 32 |
|
520.00K | $41.97M | 0.64% | New | |
| 33 |
|
1.70M | $41.66M | 0.64% | Hold | |
| 34 |
|
3.30M | $40.39M | 0.62% | New | |
| 35 |
|
8.21M | $35.12M | 0.54% Form 4 · 1 → |
Hold | |
| 36 |
|
5.12M | $34.07M | 0.52% | Hold | |
| 37 |
|
6.91M | $31.16M | 0.48% | Add | |
| 38 |
|
18.79M | $26.12M | 0.40% | Add | |
| 39 |
|
4.25M | $25.60M | 0.39% | New | |
| 40 |
|
2.40M | $25.57M | 0.39% | Hold | |
| 41 |
|
3.33M | $23.41M | 0.36% | Hold | |
| 42 |
|
863.39K | $22.20M | 0.34% | Hold | |
| 43 |
|
2.07M | $20.13M | 0.31% | Hold | |
| 44 |
|
1.95M | $19.96M | 0.30% | Hold | |
| 45 |
|
400.00K | $19.30M | 0.29% | New | |
| 46 |
|
190.00K | $18.70M | 0.29% | New | |
| 47 |
|
1.69M | $17.68M | 0.27% | Reduce | |
| 48 |
|
4.12M | $16.79M | 0.26% | Hold | |
| 49 |
|
99.00K | $16.75M | 0.26% | New | |
| 50 |
|
5.54M | $15.84M | 0.24% | Add | |
FAQ
What did RTW INVESTMENTS, LP buy in 2025-Q1?
In its 2025-Q1 13F filing, RTW INVESTMENTS, LP reported 68 equity positions worth $6.54B in aggregate; its largest disclosed positions were MDGL ($660.37M), ARGX ($398.62M), PTCT ($381.34M).
How large is RTW INVESTMENTS, LP's portfolio?
RTW INVESTMENTS, LP reported $6.54B of long equity holdings across 68 positions as of 2025-Q1. Top-10 holdings account for 52.7% of reported value.
What is RTW INVESTMENTS, LP's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.